Please assess the completion status of the following clinical trial:

Trial Title: Treatment Trial for Psychogenic Nonepileptic Seizures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Video electroencephalogram (EEG) confirmed diagnosis of NES~* Have at least one nonepileptic seizure per month~* Able to complete self report symptom scales~* Not receiving optimized sertraline~Exclusion Criteria:~* Equivocal EEG findings~* using monoamine oxidase inhibitors (MAOIs), pimozide, or sumatriptan~* allergy/sensitivity to sertraline~* current alcohol/drug dependence~* serious medical illness requiring current hospitalization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Study Arms:
- sertraline (Type: ACTIVE_COMPARATOR): flexible dose sertraline
- CBT-ip (Type: ACTIVE_COMPARATOR): cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: 12 individual, 1 hour therapy sessions
- Combined (sertraline + CBT-ip) (Type: ACTIVE_COMPARATOR): flexible dose sertraline and cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: flexible dose sertraline and 12 individual, 1 hour therapy sessions
- Standard care (Type: ACTIVE_COMPARATOR): community care / treatment as usual: routine follow up with existing providers

Based on this trial design, predict the completion outcome and termination type (if applicable).